STERIS /$STE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About STERIS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Ticker
$STE
Sector
Primary listing
NYSE
Employees
17,787
Headquarters
Website
STERIS Metrics
BasicAdvanced
$24B
37.95
$6.53
0.95
$2.28
0.92%
Price and volume
Market cap
$24B
Beta
0.95
52-week high
$253.00
52-week low
$200.98
Average daily volume
548K
Dividend rate
$2.28
Financial strength
Current ratio
2.221
Quick ratio
1.324
Long term debt to equity
29.175
Total debt to equity
29.682
Dividend payout ratio (TTM)
34.74%
Interest coverage (TTM)
14.22%
Profitability
EBITDA (TTM)
1,497.246
Gross margin (TTM)
44.36%
Net profit margin (TTM)
11.61%
Operating margin (TTM)
18.34%
Effective tax rate (TTM)
23.83%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
6.22%
Return on equity (TTM)
9.74%
Valuation
Price to earnings (TTM)
37.953
Price to revenue (TTM)
4.379
Price to book
3.51
Price to tangible book (TTM)
26.6
Price to free cash flow (TTM)
26.845
Free cash flow yield (TTM)
3.73%
Free cash flow per share (TTM)
9.231
Dividend yield (TTM)
0.92%
Forward dividend yield
0.92%
Growth
Revenue change (TTM)
6.42%
Earnings per share change (TTM)
61.94%
3-year revenue growth (CAGR)
5.29%
10-year revenue growth (CAGR)
11.54%
3-year earnings per share growth (CAGR)
20.45%
10-year earnings per share growth (CAGR)
11.30%
3-year dividend per share growth (CAGR)
9.85%
10-year dividend per share growth (CAGR)
9.50%
What the Analysts think about STERIS
Analyst ratings (Buy, Hold, Sell) for STERIS stock.
Bulls say / Bears say
Management raised reported revenue guidance for fiscal 2026 to 8–9%, up from the previous 6–7%, showing confidence in demand and pricing power underpinned by a favorable currency environment (Globe Newswire).
Free cash flow jumped 27% to $787.2 million in fiscal 2025 from $620.3 million a year prior, supported by better working capital management and higher collections, boosting the balance sheet (SEC 10-K).
Fiscal 2025 gross profit margin increased to 44.0% from 43.2% in FY 2024, benefiting from pricing, favorable mix, and productivity gains (SEC 10-K).
Steris expects a roughly $45 million negative pre-tax profit impact from new tariffs in fiscal 2026, which could limit margin expansion even as revenue rises (Globe Newswire).
The company booked a $48.15 million charge in fiscal 2025 to settle ethylene oxide emissions claims, pointing to persistent legal and environmental risks (Crain’s Cleveland Business).
Cash and cash equivalents fell to $171.7 million as of March 31, 2025 from $207.0 million at the end of fiscal 2024, weakening liquidity amid heavy capital spending and debt repayments (SEC 10-K).
Data summarised monthly by Lightyear AI. Last updated on 10 Sept 2025.
STERIS Financial Performance
Revenues and expenses
STERIS Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept26
STERIS
DividendPayment
$0.63Per share
FAQs
What’s the current market cap for STERIS stock?
STERIS (STE) has a market cap of $24B as of September 16, 2025.
What is the P/E ratio for STERIS stock?
The price to earnings (P/E) ratio for STERIS (STE) stock is 37.95 as of September 16, 2025.
Does STERIS stock pay dividends?
Yes, the STERIS (STE) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $2.28 and the yield is 0.92%. STERIS has a payout ratio of 34.74% on a trailing twelve-month basis.
When is the next STERIS dividend payment date?
The next STERIS (STE) dividend payment is scheduled for September 26, 2025.
What is the beta indicator for STERIS ?
STERIS (STE) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.